383 related articles for article (PubMed ID: 26666336)
1. Risk of de novo post-transplant type 2 diabetes in patients undergoing liver transplant for non-alcoholic steatohepatitis.
Stepanova M; Henry L; Garg R; Kalwaney S; Saab S; Younossi Z
BMC Gastroenterol; 2015 Dec; 15():175. PubMed ID: 26666336
[TBL] [Abstract][Full Text] [Related]
2. The post-transplant course of patients undergoing liver transplantation for nonalcoholic steatohepatitis versus cryptogenic cirrhosis: a retrospective case-control study.
Unger LW; Herac M; Staufer K; Salat A; Silberhumer G; Hofmann M; Trauner M; Rasoul-Rockenschaub S; Soliman T; Reiberger T; Berlakovich GA
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):309-316. PubMed ID: 27922486
[TBL] [Abstract][Full Text] [Related]
3. Post-transplantation outcome in non-alcoholic steatohepatitis cirrhosis: Comparison with alcoholic cirrhosis.
Castelló B; Aguilera V; Blázquez MT; Rubín Á; García M; Vinaixa C; Benlloch S; SanJuan F; Montalva E; López R; Berenguer M
Ann Hepatol; 2019; 18(6):855-861. PubMed ID: 31543468
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
[TBL] [Abstract][Full Text] [Related]
5. Weight Gain and
Lattanzi B; D'Ambrosio D; Tavano D; Pitoni D; Mennini G; Ginanni Corradini S; Rossi M; Merli M
Nutrients; 2019 Dec; 11(12):. PubMed ID: 31835505
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for NASH cirrhosis is not performed at the expense of major post-operative morbidity.
van den Berg EH; Douwes RM; de Meijer VE; Schreuder TCMA; Blokzijl H
Dig Liver Dis; 2018 Jan; 50(1):68-75. PubMed ID: 28935188
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis.
Saeed N; Glass L; Sharma P; Shannon C; Sonnenday CJ; Tincopa MA
Transplantation; 2019 Nov; 103(11):e345-e354. PubMed ID: 31415032
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis recurrence and rate of fibrosis progression following liver transplantation.
Sourianarayanane A; Arikapudi S; McCullough AJ; Humar A
Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):481-487. PubMed ID: 28253211
[TBL] [Abstract][Full Text] [Related]
9. Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients.
Losurdo G; Castellaneta A; Rendina M; Carparelli S; Leandro G; Di Leo A
Aliment Pharmacol Ther; 2018 Mar; 47(6):704-714. PubMed ID: 29359341
[TBL] [Abstract][Full Text] [Related]
10. Impact of renal impairment on cardiovascular disease mortality after liver transplantation for nonalcoholic steatohepatitis cirrhosis.
VanWagner LB; Lapin B; Skaro AI; Lloyd-Jones DM; Rinella ME
Liver Int; 2015 Dec; 35(12):2575-83. PubMed ID: 25977117
[TBL] [Abstract][Full Text] [Related]
11. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
[TBL] [Abstract][Full Text] [Related]
12. Improved survival outcomes in patients with non-alcoholic steatohepatitis and alcoholic liver disease following liver transplantation: an analysis of 2002-2012 United Network for Organ Sharing data.
Wong RJ; Chou C; Bonham CA; Concepcion W; Esquivel CO; Ahmed A
Clin Transplant; 2014 Jun; 28(6):713-21. PubMed ID: 24654688
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular mortality among liver transplant recipients with nonalcoholic steatohepatitis in the United States-a retrospective study.
Satapathy SK; Jiang Y; Eason JD; Kedia SK; Wong E; Singal AK; Tolley EA; Hathaway D; Nair S; Vanatta JM
Transpl Int; 2017 Oct; 30(10):1051-1060. PubMed ID: 28622441
[TBL] [Abstract][Full Text] [Related]
14. The impact of type 2 diabetes and obesity on the long-term outcomes of more than 85 000 liver transplant recipients in the US.
Younossi ZM; Stepanova M; Saab S; Kalwaney S; Clement S; Henry L; Frost S; Hunt S
Aliment Pharmacol Ther; 2014 Sep; 40(6):686-94. PubMed ID: 25040315
[TBL] [Abstract][Full Text] [Related]
15. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathologic features of de novo non-alcoholic steatohepatitis in the post-transplant setting.
Balitzer D; Tsai JH; Gill RM
Diagn Pathol; 2022 Aug; 17(1):65. PubMed ID: 35948927
[TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic steatohepatitis in posttransplantation liver: Review article.
Andrade ARCF; Cotrim HP; Bittencourt PL; Almeida CG; Sorte NCAB
Rev Assoc Med Bras (1992); 2018 Feb; 64(2):187-194. PubMed ID: 29641680
[TBL] [Abstract][Full Text] [Related]
18. Waiting List Mortality and Transplant Rates for NASH Cirrhosis When Compared With Cryptogenic, Alcoholic, or AIH Cirrhosis.
Thuluvath PJ; Hanish S; Savva Y
Transplantation; 2019 Jan; 103(1):113-121. PubMed ID: 29985186
[TBL] [Abstract][Full Text] [Related]
19. Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.
Golabi P; Bush H; Stepanova M; Locklear CT; Jacobson IM; Mishra A; Trimble G; Erario M; Venkatesan C; Younossi I; Goodman Z; Younossi ZM
Medicine (Baltimore); 2018 Aug; 97(31):e11518. PubMed ID: 30075518
[TBL] [Abstract][Full Text] [Related]
20. De Novo Colorectal and Pancreatic Cancer in Liver-Transplant Recipients: Identifying the Higher-Risk Populations.
Nasser-Ghodsi N; Mara K; Watt KD
Hepatology; 2021 Aug; 74(2):1003-1013. PubMed ID: 33544906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
